+Search query
-Structure paper
| Title | Comprehensive Chemoproteomics Unveils Selective HMG-CoA Synthase 1 Inhibitors for Targeting Mevalonate Metabolism in Cancer. |
|---|---|
| Journal, issue, pages | J Am Chem Soc, Vol. 148, Issue 20, Page 20705-20719, Year 2026 |
| Publish date | May 27, 2026 |
Authors | Liang Sun / Sang Ah Yi / Brittany Q Pham / Antoine Mocellin / Sagnik Sen / M Jason de la Cruz / Alban Ordureau / Heeseon An / ![]() |
| PubMed Abstract | Comprehensive target validation remains a significant bottleneck in chemical probe development, particularly for covalent inhibitors, where off-target reactivity can lead to toxicity. Using HMG-CoA ...Comprehensive target validation remains a significant bottleneck in chemical probe development, particularly for covalent inhibitors, where off-target reactivity can lead to toxicity. Using HMG-CoA synthase 1 (HMGCS1), an underexplored gatekeeper enzyme in the mevalonate pathway, we demonstrate how integrating orthogonal chemoproteomic methods can provide unbiased, comprehensive insights into the on- and off-target profiles of covalent inhibitors. Our study specifically highlights the limitations of traditional enrichment proteomics in distinguishing high-occupancy binders from low-occupancy binders, and it proposes a solution through a complementary scavenging proteomics approach that analyzes de-enriched fractions, providing target engagement ratios across the proteome. This framework facilitated the development of CNP7, a cyanopyrrolidine that covalently modifies HMGCS1's catalytic cysteine with remarkable selectivity, as assessed by comprehensive chemoproteomics. A 2.29 Å cryo-EM structure reveals how CNP7 engages the catalytic cysteine within HMGCS1's hydrophobic pocket. CNP7 treatment decreases HMG-CoA levels and induces global protein deprenylation within 4 h. Notably, CNP7 exhibits cell line-specific anticancer activity patterns that differ from those of statins, suggesting possible pathway node-specific vulnerabilities. Together, our study offers valuable chemical tools to modulate HMGCS1 activity and presents a framework for the rigorous characterization of covalent inhibitors in chemical biology and drug development. |
External links | J Am Chem Soc / PubMed:42127206 / PubMed Central |
| Methods | EM (single particle) |
| Resolution | 2.29 Å |
| Structure data | EMDB-73971, PDB-9zaw: |
| Chemicals | ![]() PDB-1c1c: |
| Source |
|
Keywords | TRANSFERASE / cytosolic protein / metabolic inhibitor |
Movie
Controller
Structure viewers
About Yorodumi Papers



Authors

External links


homo sapiens (human)
Keywords